OrbiMed Advisors »

Aerovate Therapeutics shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $17M 757k 22.63
2023-09-30 $10M 757k 13.57
2023-06-30 $13M 757k 17.15
2023-03-31 $15M 757k 20.17
2022-12-31 $22M 760k 29.30
2022-09-30 $13M 795k 16.58
2022-06-30 $7.5M 479k 15.63
2022-03-31 $9.3M 510k 18.33
2021-12-31 $6.3M 536k 11.79
2021-09-30 $11M 536k 20.98
2021-06-30 $12M 536k 22.83